Cargando…
Absolute quantification of donor‐derived cell‐free DNA as a marker of rejection and graft injury in kidney transplantation: Results from a prospective observational study
Donor‐derived cell‐free DNA (dd‐cfDNA) is a noninvasive biomarker for comprehensive monitoring of allograft injury and rejection in kidney transplantation (KTx). dd‐cfDNA quantification of copies/mL plasma (dd‐cfDNA[cp/mL]) was compared to dd‐cfDNA fraction (dd‐cfDNA[%]) at prespecified visits in 18...
Autores principales: | Oellerich, Michael, Shipkova, Maria, Asendorf, Thomas, Walson, Philip D., Schauerte, Verena, Mettenmeyer, Nina, Kabakchiev, Mariana, Hasche, Georg, Gröne, Hermann‐Josef, Friede, Tim, Wieland, Eberhard, Schwenger, Vedat, Schütz, Ekkehard, Beck, Julia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6899936/ https://www.ncbi.nlm.nih.gov/pubmed/31062511 http://dx.doi.org/10.1111/ajt.15416 |
Ejemplares similares
-
Absolute or Relative Quantification of Donor-derived Cell-free DNA in Kidney Transplant Recipients: Case Series
por: Osmanodja, Bilgin, et al.
Publicado: (2021) -
Donor-derived cell-free DNA as a diagnostic tool in transplantation
por: Oellerich, Michael, et al.
Publicado: (2022) -
Donor-Derived Cell-Free DNA in Biopsy-Proven Antibody-Mediated Rejection Versus Recurrent IgA Nephropathy After Kidney Transplantation
por: Akifova, Aylin, et al.
Publicado: (2023) -
Graft-derived cell-free DNA, a noninvasive early rejection and graft damage marker in liver transplantation: A prospective, observational, multicenter cohort study
por: Schütz, Ekkehard, et al.
Publicado: (2017) -
Donor-Derived Cell-Free DNA for Kidney Allograft Surveillance after Conversion to Belatacept: Prospective Pilot Study
por: Osmanodja, Bilgin, et al.
Publicado: (2023)